These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 9894580

  • 21. Amisulpride versus placebo in the medium-term treatment of the negative symptoms of schizophrenia.
    Loo H, Poirier-Littre MF, Theron M, Rein W, Fleurot O.
    Br J Psychiatry; 1997 Jan; 170():18-22. PubMed ID: 9068769
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Improvement of schizophrenic patients with primary negative symptoms treated with amisulpride. Amisulpride Study Group.
    Danion JM, Rein W, Fleurot O.
    Am J Psychiatry; 1999 Apr; 156(4):610-6. PubMed ID: 10200742
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Clinical advantages of amisulpride in the treatment of acute schizophrenia.
    Burns T, Bale R.
    J Int Med Res; 2001 Apr; 29(6):451-66. PubMed ID: 11803729
    [Abstract] [Full Text] [Related]

  • 30. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Bressan RA, Erlandsson K, Spencer EP, Ell PJ, Pilowsky LS.
    Psychopharmacology (Berl); 2004 Sep; 175(3):367-73. PubMed ID: 14997280
    [Abstract] [Full Text] [Related]

  • 31. [Plasma prolactin level and incidence of adverse endocrinologic effects during therapy with atypical neuroleptics].
    Fric M, Laux G.
    Psychiatr Prax; 2003 May; 30 Suppl 2():S97-101. PubMed ID: 14509051
    [Abstract] [Full Text] [Related]

  • 32. Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.
    Leucht S, Pitschel-Walz G, Engel RR, Kissling W.
    Am J Psychiatry; 2002 Feb; 159(2):180-90. PubMed ID: 11823257
    [Abstract] [Full Text] [Related]

  • 33. [Evaluation of efficacy and tolerance of amisulpride in treatment of schizophrenic psychoses].
    Chabannes JP, Pelissolo A, Farah S, Gerard D.
    Encephale; 1998 Feb; 24(4):386-92. PubMed ID: 9809244
    [Abstract] [Full Text] [Related]

  • 34. The neuroendocrinological profile of roxindole, a dopamine autoreceptor agonist, in schizophrenic patients.
    Gründer G, Wetzel H, Hillert A, Jochum E, Hiemke C, Benkert O.
    Psychopharmacology (Berl); 1995 Feb; 117(4):472-8. PubMed ID: 7604150
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Which role for amisulpride in rehabilitation of schizophrenic patients with acute exacerbation?
    Blin O.
    Encephale; 2000 Oct; 26 Spec No 1():7-11. PubMed ID: 11294060
    [Abstract] [Full Text] [Related]

  • 37. Catechol-O-methyltransferase gene variants may associate with negative symptom response and plasma concentrations of prolactin in schizophrenia after amisulpride treatment.
    Chen CY, Yeh YW, Kuo SC, Ho PS, Liang CS, Yen CH, Lu RB, Huang SY.
    Psychoneuroendocrinology; 2016 Mar; 65():67-75. PubMed ID: 26724569
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Treatment of negative symptoms in schizophrenia by amisulpride. Review of the literature].
    Pélissolo A, Krebs MO, Olié JP.
    Encephale; 1996 Mar; 22(3):215-9. PubMed ID: 8767050
    [Abstract] [Full Text] [Related]

  • 40. Amisulpride-induced hyperprolactinemia is reversible following discontinuation.
    Paparrigopoulos T, Liappas J, Tzavellas E, Mourikis I, Soldatos C.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan 30; 31(1):92-6. PubMed ID: 16938372
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.